161 related articles for article (PubMed ID: 32069257)
1. Epidemiology and mortality in bacterial bloodstream infections in patients with hematologic malignancies.
Mert D; Ceken S; Iskender G; Iskender D; Merdin A; Duygu F; Ertek M; Altuntas F
J Infect Dev Ctries; 2019 Aug; 13(8):727-735. PubMed ID: 32069257
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies.
Kara Ö; Zarakolu P; Aşçioğlu S; Etgül S; Uz B; Büyükaşik Y; Akova M
Infect Dis (Lond); 2015; 47(10):686-93. PubMed ID: 26024284
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of Pathogenic Bacterial Spectrum, Drug Resistance and Risk Factors for Mortality of Bloodstream Infection in Patients with Hematologic Diseases].
Guo Q; Wang XW; Chen XY; Zhao J; He SL; Tian WW; Ma LM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1556-1562. PubMed ID: 37846716
[TBL] [Abstract][Full Text] [Related]
4. [Single Center Analysis of Bloodstream Infection Clinical Characteristics and Prognosis in Patients with Hematological Malignancies in the Tropics].
Cheng LC; Yang T; Kuang HH; Yu S; Guan LX; Gu ZY; Xu YY; Zheng WS; Wang L; Hu YL; Gao XN; Wang QS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Feb; 29(1):265-271. PubMed ID: 33554832
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Bacterial Biofilms on End-Organ Disease and Mortality in Patients with Hematologic Malignancies Developing a Bloodstream Infection.
Di Domenico EG; Marchesi F; Cavallo I; Toma L; Sivori F; Papa E; Spadea A; Cafarella G; Terrenato I; Prignano G; Pimpinelli F; Mastrofrancesco A; D'Agosto G; Trento E; Morrone A; Mengarelli A; Ensoli F
Microbiol Spectr; 2021 Sep; 9(1):e0055021. PubMed ID: 34406812
[TBL] [Abstract][Full Text] [Related]
6. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies.
Trecarichi EM; Tumbarello M; Spanu T; Caira M; Fianchi L; Chiusolo P; Fadda G; Leone G; Cauda R; Pagano L
J Infect; 2009 Apr; 58(4):299-307. PubMed ID: 19272650
[TBL] [Abstract][Full Text] [Related]
7. Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy.
Chen CY; Tang JL; Hsueh PR; Yao M; Huang SY; Chen YC; Chen YC; Shen MC; Wang CH; Tsai W; Chang SC; Tien HF; Luh KT
J Formos Med Assoc; 2004 Jul; 103(7):526-32. PubMed ID: 15318274
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of pathogens and clinical characteristics of bloodstream infection in neutropenic children with hematological malignancies from 2014 to 2018].
Zhu GQ; Xu CH; Lin QS; Wang XX; Wang LL; Zhao NN; Feng SZ; Chen YM
Zhonghua Xue Ye Xue Za Zhi; 2020 Aug; 41(8):655-660. PubMed ID: 32942819
[No Abstract] [Full Text] [Related]
9. Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey.
Trecarichi EM; Pagano L; Candoni A; Pastore D; Cattaneo C; Fanci R; Nosari A; Caira M; Spadea A; Busca A; Vianelli N; Tumbarello M;
Clin Microbiol Infect; 2015 Apr; 21(4):337-43. PubMed ID: 25595706
[TBL] [Abstract][Full Text] [Related]
10. [A single-center study on the distribution and antibiotic resistance of pathogens causing bloodstream infection in patients with hematological malignancies].
Cai LJ; Wei XL; Wei YQ; Guo XT; Jiang XJ; Zhang Y; Yu GP; Dai M; Ye JY; Zhou HS; Xu D; Huang F; Fan ZP; Xu N; Shi PC; Xuan L; Feng R; Liu XL; Sun J; Liu QF
Zhonghua Xue Ye Xue Za Zhi; 2023 Jun; 44(6):479-483. PubMed ID: 37550203
[No Abstract] [Full Text] [Related]
11. Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria.
Cattaneo C; Di Blasi R; Skert C; Candoni A; Martino B; Di Renzo N; Delia M; Ballanti S; Marchesi F; Mancini V; Orciuolo E; Cesaro S; Prezioso L; Fanci R; Nadali G; Chierichini A; Facchini L; Picardi M; Malagola M; Orlando V; Trecarichi EM; Tumbarello M; Aversa F; Rossi G; Pagano L;
Ann Hematol; 2018 Sep; 97(9):1717-1726. PubMed ID: 29705860
[TBL] [Abstract][Full Text] [Related]
12. [Distribution and drug resistance of pathogens of blood stream infection in patients with hematological malignancies after chemotherapy].
Chen SZ; Lin KN; Xiao M; Luo XF; Li Q; Ren JH; Huang RY; Chen MM; Ally ZZ; Chen T; Yang JD; Hu J
Zhonghua Xue Ye Xue Za Zhi; 2017 Nov; 38(11):951-955. PubMed ID: 29224318
[No Abstract] [Full Text] [Related]
13. Comparison of the epidemiology and microbiology of peripheral line- and central line-associated bloodstream infections.
Tsuboi M; Hayakawa K; Mezaki K; Katanami Y; Yamamoto K; Kutsuna S; Takeshita N; Ohmagari N
Am J Infect Control; 2019 Feb; 47(2):208-210. PubMed ID: 30337129
[TBL] [Abstract][Full Text] [Related]
14. Frequency of bacterial isolates and pattern of antimicrobial resistance in patients with hematological malignancies: A snapshot from tertiary cancer center.
Sengar M; Kelkar R; Jain H; Biswas S; Pawaskar P; Karpe A
Indian J Cancer; 2014; 51(4):456-8. PubMed ID: 26842160
[TBL] [Abstract][Full Text] [Related]
15. [Epidemiology and prognosis of patients with bloodstream infection in 10 hospitals in Colombia].
De La Rosa G; León AL; Jaimes F
Rev Chilena Infectol; 2016 Apr; 33(2):141-9. PubMed ID: 27314991
[TBL] [Abstract][Full Text] [Related]
16. Associated factors and clinical outcomes of bloodstream infection due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae during febrile neutropenia.
Ben-Chetrit E; Eldaim MA; Bar-Meir M; Dodin M; Katz DE
Int J Antimicrob Agents; 2019 Apr; 53(4):423-428. PubMed ID: 30572008
[TBL] [Abstract][Full Text] [Related]
17. Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008-2013.
Chen CY; Tien FM; Sheng WH; Huang SY; Yao M; Tang JL; Tsay W; Tien HF; Hsueh PR
Int J Antimicrob Agents; 2017 Mar; 49(3):272-281. PubMed ID: 28109554
[TBL] [Abstract][Full Text] [Related]
18. Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode.
Demirel A; Tabak F; Ar MC; Mete B; Öngören Ş; Yemişen M; Özaras R; Eşkazan E; Başlar Z; Mert A; Soysal T; Ferhanoğlu B; Aydın Y; Öztürk R
Turk J Haematol; 2015 Sep; 32(3):243-50. PubMed ID: 25913035
[TBL] [Abstract][Full Text] [Related]
19. Emergence of multidrug resistant isolates and mortality predictors in patients with solid tumors or hematological malignancies.
Bastug A; Kayaaslan B; Kazancioglu S; But A; Aslaner H; Akinci E; Yetkin MA; Kanyilmaz D; Eren SS; Bodur H
J Infect Dev Ctries; 2015 Oct; 9(10):1100-7. PubMed ID: 26517485
[TBL] [Abstract][Full Text] [Related]
20. [Antibiotic Resistance and Risk Factors for Mortality of Blood Stream Infections (BSIs) with
Zhang WL; Huang J; Wu SY; Liu Y; Long F; Xiao YL; Xie Y; He C; Kang M
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):133-135. PubMed ID: 29737104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
